Mitch William E
Nephrology Division, Baylor College of Medicine, Houston, Texas 77030, USA.
J Clin Invest. 2005 Jun;115(6):1476-8. doi: 10.1172/JCI25255.
Anorexia is one of several abnormalities characterizing chronic kidney disease (CKD) that cause cachexia, the loss of muscle and adipose stores. It has been attributed to mechanisms ranging from accumulation of toxic "middle molecules" to psychological problems. In this issue of the JCI, Cheung and coworkers used elegant techniques to demonstrate that CKD-associated anorexia is caused by defective hypothalamic regulation of appetite. They attributed the defect to an alteration in the hypothalamus's response to leptin and inflammation. Since similar hypothalamic defects suppress appetite in inflammatory states and in cancer, it is possible that anorexia in several cachexia-inducing conditions results from a common set of hypothalamic abnormalities. The development of small molecules capable of preventing these regulatory abnormalities holds the promise of eliminating the contribution of anorexia to the development of cachexia.
厌食是慢性肾脏病(CKD)的几种异常表现之一,这些异常会导致恶病质,即肌肉和脂肪储备的流失。其病因涵盖多种机制,从有毒“中分子”的蓄积到心理问题。在本期《临床研究杂志》(JCI)中,张及其同事运用精妙技术证明,CKD相关的厌食是由下丘脑对食欲的调节缺陷所致。他们将此缺陷归因于下丘脑对瘦素和炎症反应的改变。鉴于类似的下丘脑缺陷会在炎症状态和癌症中抑制食欲,那么在几种导致恶病质的病症中,厌食可能是由一组共同的下丘脑异常所引起。能够预防这些调节异常的小分子的研发,有望消除厌食对恶病质发展的影响。